| H0019 | Behavioral health; long‑term residential (non‑medical, non‑acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem | 59 | 80 | 14,670 | $280 | $9.3M |
| G0378 | Hospital observation service, per hour | 49 | 80 | 6,290 | $690 | $6.6M |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 126 | 170 | 21,080 | $100 | $4.2M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 72 | 130 | 3,180 | $60 | $4.2M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 73 | 260 | 4,240 | $220 | $4.1M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 85 | 320 | 580 | $230 | $4M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 88 | 280 | 920 | $200 | $2.6M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 58 | 150 | 3,680 | $30 | $1.5M |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 46 | 140 | 1,410 | $180 | $1.3M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 30 | 110 | 1,810 | $50 | $930.1K |